rs11755562

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001365276.2(TNXB):​c.12378C>T​(p.Asp4126Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0060 ( 0 hom., cov: 9)
Exomes 𝑓: 0.0084 ( 16 hom. )
Failed GnomAD Quality Control

Consequence

TNXB
NM_001365276.2 synonymous

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -6.51

Publications

1 publications found
Variant links:
Genes affected
TNXB (HGNC:11976): (tenascin XB) This gene encodes a member of the tenascin family of extracellular matrix glycoproteins. The tenascins have anti-adhesive effects, as opposed to fibronectin which is adhesive. This protein is thought to function in matrix maturation during wound healing, and its deficiency has been associated with the connective tissue disorder Ehlers-Danlos syndrome. This gene localizes to the major histocompatibility complex (MHC) class III region on chromosome 6. It is one of four genes in this cluster which have been duplicated. The duplicated copy of this gene is incomplete and is a pseudogene which is transcribed but does not encode a protein. The structure of this gene is unusual in that it overlaps the CREBL1 and CYP21A2 genes at its 5' and 3' ends, respectively. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
TNXB Gene-Disease associations (from GenCC):
  • Ehlers-Danlos syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • Ehlers-Danlos syndrome due to tenascin-X deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Illumina, PanelApp Australia, Orphanet
  • familial vesicoureteral reflux
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • vesicoureteral reflux 8
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 6-32042103-G-A is Benign according to our data. Variant chr6-32042103-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 261123.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-6.51 with no splicing effect.
BS1
Variant frequency is greater than expected in population eas. GnomAdExome4 allele frequency = 0.0084 (4220/502122) while in subpopulation EAS AF = 0.043 (1355/31478). AF 95% confidence interval is 0.0411. There are 16 homozygotes in GnomAdExome4. There are 2317 alleles in the male GnomAdExome4 subpopulation. Median coverage is 5. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 16 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TNXBNM_001365276.2 linkc.12378C>T p.Asp4126Asp synonymous_variant Exon 42 of 44 ENST00000644971.2 NP_001352205.1
TNXBNM_001428335.1 linkc.13119C>T p.Asp4373Asp synonymous_variant Exon 43 of 45 NP_001415264.1
TNXBNM_019105.8 linkc.12372C>T p.Asp4124Asp synonymous_variant Exon 42 of 44 NP_061978.6
TNXBNM_032470.4 linkc.1665C>T p.Asp555Asp synonymous_variant Exon 11 of 13 NP_115859.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TNXBENST00000644971.2 linkc.12378C>T p.Asp4126Asp synonymous_variant Exon 42 of 44 NM_001365276.2 ENSP00000496448.1

Frequencies

GnomAD3 genomes
AF:
0.00601
AC:
418
AN:
69564
Hom.:
0
Cov.:
9
show subpopulations
Gnomad AFR
AF:
0.00208
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00789
Gnomad ASJ
AF:
0.0362
Gnomad EAS
AF:
0.0122
Gnomad SAS
AF:
0.0113
Gnomad FIN
AF:
0.000265
Gnomad MID
AF:
0.0202
Gnomad NFE
AF:
0.00580
Gnomad OTH
AF:
0.00820
GnomAD2 exomes
AF:
0.00735
AC:
685
AN:
93208
AF XY:
0.00791
show subpopulations
Gnomad AFR exome
AF:
0.000838
Gnomad AMR exome
AF:
0.00472
Gnomad ASJ exome
AF:
0.0276
Gnomad EAS exome
AF:
0.0105
Gnomad FIN exome
AF:
0.00195
Gnomad NFE exome
AF:
0.00482
Gnomad OTH exome
AF:
0.0110
GnomAD4 exome
AF:
0.00840
AC:
4220
AN:
502122
Hom.:
16
Cov.:
5
AF XY:
0.00873
AC XY:
2317
AN XY:
265334
show subpopulations
African (AFR)
AF:
0.00196
AC:
29
AN:
14768
American (AMR)
AF:
0.00503
AC:
154
AN:
30608
Ashkenazi Jewish (ASJ)
AF:
0.0295
AC:
459
AN:
15536
East Asian (EAS)
AF:
0.0430
AC:
1355
AN:
31478
South Asian (SAS)
AF:
0.0117
AC:
622
AN:
53206
European-Finnish (FIN)
AF:
0.000913
AC:
28
AN:
30654
Middle Eastern (MID)
AF:
0.0265
AC:
58
AN:
2192
European-Non Finnish (NFE)
AF:
0.00443
AC:
1310
AN:
295654
Other (OTH)
AF:
0.00731
AC:
205
AN:
28026
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
184
367
551
734
918
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.00599
AC:
417
AN:
69612
Hom.:
0
Cov.:
9
AF XY:
0.00648
AC XY:
198
AN XY:
30552
show subpopulations
African (AFR)
AF:
0.00202
AC:
35
AN:
17352
American (AMR)
AF:
0.00787
AC:
49
AN:
6226
Ashkenazi Jewish (ASJ)
AF:
0.0362
AC:
63
AN:
1740
East Asian (EAS)
AF:
0.0123
AC:
37
AN:
3012
South Asian (SAS)
AF:
0.0113
AC:
23
AN:
2040
European-Finnish (FIN)
AF:
0.000265
AC:
1
AN:
3770
Middle Eastern (MID)
AF:
0.0221
AC:
5
AN:
226
European-Non Finnish (NFE)
AF:
0.00580
AC:
197
AN:
33980
Other (OTH)
AF:
0.00806
AC:
7
AN:
868
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
15
30
45
60
75
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00879
Hom.:
6

ClinVar

Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Ehlers-Danlos syndrome Benign:1
Jul 08, 2021
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.77
CADD
Benign
1.9
DANN
Benign
0.90
PhyloP100
-6.5
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11755562; hg19: chr6-32009880; COSMIC: COSV64480218; COSMIC: COSV64480218; API